Anhui Fengyuan Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
Anhui Fengyuan Pharmaceutical has a total shareholder equity of CN¥2.0B and total debt of CN¥828.0M, which brings its debt-to-equity ratio to 42%. Its total assets and total liabilities are CN¥4.7B and CN¥2.7B respectively. Anhui Fengyuan Pharmaceutical's EBIT is CN¥254.2M making its interest coverage ratio -47.6. It has cash and short-term investments of CN¥335.9M.
Key information
42.0%
Debt to equity ratio
CN¥828.02m
Debt
Interest coverage ratio | -47.6x |
Cash | CN¥335.91m |
Equity | CN¥1.97b |
Total liabilities | CN¥2.73b |
Total assets | CN¥4.70b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 000153's short term assets (CN¥2.1B) do not cover its short term liabilities (CN¥2.3B).
Long Term Liabilities: 000153's short term assets (CN¥2.1B) exceed its long term liabilities (CN¥479.4M).
Debt to Equity History and Analysis
Debt Level: 000153's net debt to equity ratio (25%) is considered satisfactory.
Reducing Debt: 000153's debt to equity ratio has increased from 26.7% to 42% over the past 5 years.
Debt Coverage: 000153's debt is well covered by operating cash flow (30.3%).
Interest Coverage: 000153 earns more interest than it pays, so coverage of interest payments is not a concern.